샘플 요청 목록

 카트 문의
시장보고서
상품코드
1773816

효소면역측정법 시장

Enzyme Immunoassays
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 487 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

효소면역측정법 세계 시장은 2030년까지 211억 달러에 달할 전망

2024년에 178억 달러로 추정되는 효소면역측정법 세계 시장은 2024년부터 2030년까지 CAGR 2.9%로 성장하여 2030년에는 211억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 시약·키트는 CAGR 2.7%를 기록하며 분석 기간 종료시에는 132억 달러에 달할 것으로 예측됩니다. 분석기/기기 부문의 성장률은 분석 기간 동안 CAGR 3.5%로 추정됩니다.

미국 시장은 추정 49억 달러, 중국은 CAGR 5.4%로 성장 예측

미국의 효소면역측정법 시장은 2024년에 49억 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 41억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 5.4%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 1.1%와 2.2%로 예측됩니다. 유럽에서는 독일이 CAGR 1.6%로 성장할 것으로 예측됩니다.

세계의 효소면역측정법 시장 - 주요 동향과 촉진요인 정리

효소면역측정법(EIA)이 진단 검사에서 점점 더 중요해지는 이유는 무엇일까?

효소면역측정법(EIA)은 바이오마커, 병원체, 항체를 신속, 고감도, 특이적으로 검출하는 진단 검사에서 중요한 도구가 되었습니다. 이 기술은 높은 처리량과 저농도의 표적 분자를 검출할 수 있는 능력으로 의료 진단, 제약 연구, 환경 검사에 널리 사용되고 있습니다. 감염성 질환, 자가면역질환, 암 및 심혈관질환과 같은 만성질환의 유병률 증가가 EIA 기반 진단 솔루션에 대한 수요를 주도하고 있습니다.

효소 결합 면역 흡착법(ELISA), 화학발광면역측정법(CLIA), 다중 면역 측정법 개발 등 측정법 설계의 기술적 발전으로 민감도와 특이도가 향상되고 있습니다. 자동화와 현장 검사(POC)로의 전환은 임상 실험실 및 가정 진단에서 EIA의 채택을 더욱 확대시키고 있습니다. 질병의 조기 발견과 맞춤형 의료에 대한 수요는 신속하고 정확한 진단 결과를 제공하는 새로운 면역측정법 연구에 박차를 가하고 있습니다.

기술 혁신은 효소 면역 측정법의 효율성을 어떻게 향상시키고 있는가?

최근 효소면역측정법의 기술 혁신은 분석 성능을 향상시키고, 납기를 단축하며, 자동화 능력을 향상시키고 있습니다. 미세유체 기술의 통합으로 소형화된 고처리량 면역측정법 플랫폼의 개발이 가능해져 시약 소비를 줄이면서 효율을 높일 수 있게 되었습니다. 또한, 나노기술의 발전은 질병 바이오마커를 조기에 검출할 수 있는 초민감성 면역측정법법 개발에 기여하고 있습니다.

인공지능(AI)과 머신러닝은 면역측정 결과를 보다 정확하게 분석하고, 인위적 오류를 줄이고, 진단 정확도를 향상시키기 위해 활용되고 있습니다. 재조합 효소 및 인공 항체의 사용은 교차 반응성을 줄이고 분석의 특이성을 높여 EIA의 신뢰성을 높이고 있습니다. 신속하고 비용 효율적이며 신뢰할 수 있는 진단 도구에 대한 수요가 증가함에 따라 효소면역측정법 시장은 특히 감염성 질환 검사 및 암 바이오마커 검출 분야에서 지속적인 발전을 보일 것으로 예상됩니다.

효소면역측정법 시장의 성장을 촉진하는 주요 요인은 무엇인가?

효소면역측정법 시장의 성장은 감염성 질환 발병률 증가, 현장 진단 솔루션의 채택 증가, 면역측정 기술의 발전 등 여러 요인에 기인합니다. 질병의 조기 발견에 대한 수요 증가와 바이오마커 탐색 연구의 확대는 고감도, 고특이도의 EIA 기반 검사에 대한 수요를 촉진하고 있습니다. 또한, 진단의 진보에 대한 규제 당국의 승인과 정부의 재정적 지원이 시장 확대를 뒷받침하고 있습니다.

특히 만성질환 자가 모니터링 및 감염성 질환 검사를 위한 가정용 및 휴대용 면역측정 키트의 등장은 시장 성장에 더욱 기여하고 있습니다. 제약 및 생명공학 산업도 의약품 개발, 치료 모니터링, 백신 연구 분야에서 면역측정법에 대한 수요를 주도하고 있습니다. 의료 서비스 제공자와 연구자들이 정밀 진단에 대한 투자를 지속하는 가운데, 진단 검사의 속도, 정확성, 자동화 향상에 초점을 맞춘 기술 혁신으로 효소면역측정법 시장은 크게 성장할 것으로 예상됩니다.

부문

제품(시약 및 키트, 분석기/기기, 소프트웨어 및 서비스), 검체(혈액, 타액, 소변, 기타 검체), 용도(치료제 모니터링, 종양학, 순환기학, 내분비학, 감염증 검사, 자가면역질환, 기타), 최종 용도(병원, 혈액은행, 임상 검사실, 제약 및 바이오테크놀러지 기업, 학술 연구 센터, 기타)

조사 대상 기업 사례

  • Abbott Laboratories
  • Arlington Scientific, Inc.
  • Becton, Dickinson and Company
  • Biobase Biodustry(Shandong) Co., Ltd.
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Carolina Liquid Chemistries Corp.
  • Charles River Laboratories
  • Danaher Corporation(Beckman Coulter)
  • DiaSorin S.p.A.
  • Diazyme Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • Illumina, Inc.
  • Ortho Clinical Diagnostics
  • Qiagen N.V.
  • QuidelOrtho Corporation
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 일반적인 LLM 및 업계별 SLM 쿼리를 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 25.07.25

Global Enzyme Immunoassays Market to Reach US$21.1 Billion by 2030

The global market for Enzyme Immunoassays estimated at US$17.8 Billion in the year 2024, is expected to reach US$21.1 Billion by 2030, growing at a CAGR of 2.9% over the analysis period 2024-2030. Reagents & Kits, one of the segments analyzed in the report, is expected to record a 2.7% CAGR and reach US$13.2 Billion by the end of the analysis period. Growth in the Analyzers / Instruments segment is estimated at 3.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.9 Billion While China is Forecast to Grow at 5.4% CAGR

The Enzyme Immunoassays market in the U.S. is estimated at US$4.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.1 Billion by the year 2030 trailing a CAGR of 5.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.1% and 2.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.6% CAGR.

Global Enzyme Immunoassay Market - Key Trends & Drivers Summarized

Why Is Enzyme Immunoassay (EIA) Gaining Importance in Diagnostic Testing?

Enzyme immunoassay (EIA) has become a critical tool in diagnostic testing, providing rapid, sensitive, and specific detection of biomarkers, pathogens, and antibodies. The technique is widely used in medical diagnostics, pharmaceutical research, and environmental testing due to its high-throughput capabilities and ability to detect even low concentrations of target molecules. The increasing prevalence of infectious diseases, autoimmune disorders, and chronic conditions such as cancer and cardiovascular diseases is driving the demand for EIA-based diagnostic solutions.

Technological advancements in assay design, such as the development of enzyme-linked immunosorbent assay (ELISA) variants, chemiluminescent immunoassays (CLIA), and multiplex immunoassays, have improved sensitivity and specificity. The shift toward automation and point-of-care (POC) testing is further expanding the adoption of EIA in clinical laboratories and home-based diagnostics. The demand for early disease detection and personalized medicine is fueling research into novel immunoassay formats that provide rapid and highly accurate diagnostic results.

How Are Innovations Enhancing the Efficiency of Enzyme Immunoassays?

Recent innovations in enzyme immunoassays are improving assay performance, reducing turnaround times, and increasing automation capabilities. The integration of microfluidic technology is enabling the development of miniaturized and high-throughput immunoassay platforms, which enhance efficiency while reducing reagent consumption. Additionally, advancements in nanotechnology are contributing to the development of ultra-sensitive immunoassays that can detect disease biomarkers at an early stage.

Artificial intelligence (AI) and machine learning are being leveraged to analyze immunoassay results more accurately, reducing human errors and improving diagnostic precision. The use of recombinant enzymes and engineered antibodies is enhancing the reliability of EIA by reducing cross-reactivity and increasing assay specificity. As demand for rapid, cost-effective, and reliable diagnostic tools grows, the enzyme immunoassay market is expected to witness continuous advancements, particularly in infectious disease testing and cancer biomarker detection.

What Are the Key Factors Driving Growth in the Enzyme Immunoassay Market?

The growth in the enzyme immunoassay market is driven by several factors, including the rising incidence of infectious diseases, increasing adoption of point-of-care diagnostic solutions, and advancements in immunoassay technology. The growing need for early disease detection and the expansion of research in biomarker discovery are fueling the demand for highly sensitive and specific EIA-based tests. Additionally, regulatory approvals and government funding for diagnostic advancements are supporting market expansion.

The rise of home-based and portable immunoassay kits, particularly for self-monitoring of chronic diseases and infectious disease testing, is further contributing to market growth. The pharmaceutical and biotechnology industries are also driving demand for immunoassays in drug development, therapeutic monitoring, and vaccine research. As healthcare providers and researchers continue to invest in precision diagnostics, the enzyme immunoassay market is expected to expand significantly, with innovations focused on improving speed, accuracy, and automation in diagnostic testing.

SCOPE OF STUDY:

The report analyzes the Enzyme Immunoassays market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Reagents & Kits, Analyzers / Instruments, Software & Services); Specimen (Blood, Saliva, Urine, Other Specimens); Application (Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Others); End-Use (Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Abbott Laboratories
  • Arlington Scientific, Inc.
  • Becton, Dickinson and Company
  • Biobase Biodustry (Shandong) Co., Ltd.
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Carolina Liquid Chemistries Corp.
  • Charles River Laboratories
  • Danaher Corporation (Beckman Coulter)
  • DiaSorin S.p.A.
  • Diazyme Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • Illumina, Inc.
  • Ortho Clinical Diagnostics
  • Qiagen N.V.
  • QuidelOrtho Corporation
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Enzyme Immunoassays - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Chronic and Infectious Diseases Spurs Demand for Enzyme Immunoassay Testing
    • Technological Advancements in Microfluidics and Lab-on-a-Chip Platforms Drive Innovation in EIA
    • Growing Adoption of Point-of-Care Testing Expands Addressable Market for Enzyme Immunoassays
    • Increasing Focus on Personalized Medicine Strengthens Business Case for Highly Specific EIA Kits
    • Surge in Biopharmaceutical R&D Activities Accelerates Demand for High-Throughput EIA Solutions
    • Advancements in Multiplexing Capabilities Propel Growth of EIA in Complex Diagnostic Applications
    • Integration of Artificial Intelligence and Data Analytics Enhances Diagnostic Accuracy of EIAs
    • Regulatory Push for Standardized and Quality-Assured Diagnostics Drives Adoption of Validated EIA Kits
    • Expansion of Public Health Screening Programs Generates Sustained Demand for EIA-Based Assays
    • Growing Investments in Veterinary Diagnostics Throws the Spotlight on Animal-Specific EIA Tests
    • Rising Trend Toward Home-Based and Self-Testing Kits Opens Up New Growth Avenues for EIAs
    • Greater Awareness and Early Detection Initiatives Fuel Market Penetration in Developing Regions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Enzyme Immunoassays Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Enzyme Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Enzyme Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Enzyme Immunoassays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Reagents & Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Analyzers / Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Analyzers / Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Analyzers / Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Software & Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Endocrinology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Endocrinology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Endocrinology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Infectious Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Infectious Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Infectious Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Autoimmune Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Autoimmune Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Autoimmune Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Therapeutic Drug Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Therapeutic Drug Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Therapeutic Drug Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Blood Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Blood Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Blood Banks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Clinical Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 47: World Recent Past, Current & Future Analysis for Academic Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 48: World Historic Review for Academic Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: World 15-Year Perspective for Academic Research Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 50: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 53: World Recent Past, Current & Future Analysis for Blood by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 54: World Historic Review for Blood by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: World 15-Year Perspective for Blood by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 56: World Recent Past, Current & Future Analysis for Saliva by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 57: World Historic Review for Saliva by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: World 15-Year Perspective for Saliva by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 59: World Recent Past, Current & Future Analysis for Urine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 60: World Historic Review for Urine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: World 15-Year Perspective for Urine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 62: World Recent Past, Current & Future Analysis for Other Specimens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 63: World Historic Review for Other Specimens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: World 15-Year Perspective for Other Specimens by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Enzyme Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 65: USA Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: USA Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: USA 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 68: USA Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: USA Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: USA 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
    • TABLE 71: USA Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: USA Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: USA 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 74: USA Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: USA Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: USA 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 77: Canada Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Canada Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Canada 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 80: Canada Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Canada Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Canada 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
    • TABLE 83: Canada Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Canada Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Canada 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 86: Canada Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Canada Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Canada 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
  • JAPAN
    • Enzyme Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 89: Japan Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Japan Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Japan 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 92: Japan Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Japan Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Japan 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
    • TABLE 95: Japan Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Japan Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Japan 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 98: Japan Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Japan Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Japan 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
  • CHINA
    • Enzyme Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 101: China Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: China Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: China 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 104: China Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: China Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: China 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
    • TABLE 107: China Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: China Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: China 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 110: China Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: China Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: China 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
  • EUROPE
    • Enzyme Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 113: Europe Recent Past, Current & Future Analysis for Enzyme Immunoassays by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 114: Europe Historic Review for Enzyme Immunoassays by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Europe 15-Year Perspective for Enzyme Immunoassays by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 116: Europe Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Europe Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Europe 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 119: Europe Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Europe Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Europe 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
    • TABLE 122: Europe Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Europe Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Europe 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 125: Europe Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Europe Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Europe 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
  • FRANCE
    • Enzyme Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 128: France Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: France Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: France 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 131: France Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: France Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: France 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
    • TABLE 134: France Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: France Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: France 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 137: France Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: France Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: France 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
  • GERMANY
    • Enzyme Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 140: Germany Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Germany Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Germany 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 143: Germany Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Germany Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Germany 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
    • TABLE 146: Germany Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Germany Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Germany 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 149: Germany Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Germany Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Germany 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 152: Italy Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Italy Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Italy 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 155: Italy Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Italy Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Italy 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
    • TABLE 158: Italy Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Italy Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Italy 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 161: Italy Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Italy Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Italy 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Enzyme Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 164: UK Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: UK Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: UK 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 167: UK Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: UK Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: UK 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
    • TABLE 170: UK Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: UK Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: UK 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 173: UK Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: UK Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: UK 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 176: Spain Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Spain Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Spain 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 179: Spain Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Spain Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Spain 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
    • TABLE 182: Spain Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Spain Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Spain 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 185: Spain Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Spain Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Spain 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 188: Russia Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Russia Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Russia 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 191: Russia Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Russia Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Russia 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
    • TABLE 194: Russia Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Russia Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Russia 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 197: Russia Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Russia Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Russia 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 200: Rest of Europe Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Europe Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Europe 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Europe Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Europe Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Europe 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
    • TABLE 206: Rest of Europe Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Europe Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Europe 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 209: Rest of Europe Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Rest of Europe Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Rest of Europe 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Enzyme Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 212: Asia-Pacific Recent Past, Current & Future Analysis for Enzyme Immunoassays by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 213: Asia-Pacific Historic Review for Enzyme Immunoassays by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Asia-Pacific 15-Year Perspective for Enzyme Immunoassays by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 215: Asia-Pacific Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Asia-Pacific Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Asia-Pacific 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 218: Asia-Pacific Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Asia-Pacific Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Asia-Pacific 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
    • TABLE 221: Asia-Pacific Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Asia-Pacific Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Asia-Pacific 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 224: Asia-Pacific Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Asia-Pacific Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Asia-Pacific 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Enzyme Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 227: Australia Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Australia Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Australia 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 230: Australia Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Australia Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Australia 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
    • TABLE 233: Australia Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Australia Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Australia 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 236: Australia Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Australia Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Australia 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
  • INDIA
    • Enzyme Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 239: India Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: India Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: India 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 242: India Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: India Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: India 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
    • TABLE 245: India Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: India Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: India 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 248: India Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: India Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: India 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 251: South Korea Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: South Korea Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: South Korea 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 254: South Korea Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: South Korea Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: South Korea 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
    • TABLE 257: South Korea Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: South Korea Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: South Korea 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 260: South Korea Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: South Korea Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: South Korea 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 263: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Rest of Asia-Pacific Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Rest of Asia-Pacific 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 266: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Rest of Asia-Pacific Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Rest of Asia-Pacific 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
    • TABLE 269: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Rest of Asia-Pacific Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Rest of Asia-Pacific 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 272: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Rest of Asia-Pacific Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Rest of Asia-Pacific 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Enzyme Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 275: Latin America Recent Past, Current & Future Analysis for Enzyme Immunoassays by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 276: Latin America Historic Review for Enzyme Immunoassays by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Latin America 15-Year Perspective for Enzyme Immunoassays by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 278: Latin America Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Latin America Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Latin America 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 281: Latin America Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Latin America Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: Latin America 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
    • TABLE 284: Latin America Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Latin America Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Latin America 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 287: Latin America Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Latin America Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: Latin America 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 290: Argentina Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Argentina Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Argentina 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 293: Argentina Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Argentina Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Argentina 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
    • TABLE 296: Argentina Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Argentina Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Argentina 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 299: Argentina Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Argentina Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Argentina 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 302: Brazil Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Brazil Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Brazil 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 305: Brazil Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Brazil Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Brazil 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
    • TABLE 308: Brazil Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Brazil Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 310: Brazil 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 311: Brazil Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Brazil Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 313: Brazil 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 314: Mexico Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Mexico Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 316: Mexico 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 317: Mexico Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Mexico Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 319: Mexico 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
    • TABLE 320: Mexico Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Mexico Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 322: Mexico 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 323: Mexico Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Mexico Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 325: Mexico 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 326: Rest of Latin America Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Rest of Latin America Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 328: Rest of Latin America 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 329: Rest of Latin America Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Rest of Latin America Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 331: Rest of Latin America 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
    • TABLE 332: Rest of Latin America Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Rest of Latin America Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 334: Rest of Latin America 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 335: Rest of Latin America Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Rest of Latin America Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 337: Rest of Latin America 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Enzyme Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 338: Middle East Recent Past, Current & Future Analysis for Enzyme Immunoassays by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 339: Middle East Historic Review for Enzyme Immunoassays by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 340: Middle East 15-Year Perspective for Enzyme Immunoassays by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 341: Middle East Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Middle East Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 343: Middle East 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 344: Middle East Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Middle East Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 346: Middle East 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
    • TABLE 347: Middle East Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Middle East Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 349: Middle East 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 350: Middle East Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Middle East Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 352: Middle East 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 353: Iran Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Iran Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 355: Iran 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 356: Iran Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Iran Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 358: Iran 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
    • TABLE 359: Iran Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 360: Iran Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 361: Iran 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 362: Iran Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 363: Iran Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 364: Iran 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 365: Israel Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 366: Israel Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 367: Israel 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 368: Israel Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 369: Israel Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 370: Israel 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
    • TABLE 371: Israel Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 372: Israel Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 373: Israel 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 374: Israel Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 375: Israel Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 376: Israel 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 377: Saudi Arabia Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 378: Saudi Arabia Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 379: Saudi Arabia 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 380: Saudi Arabia Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 381: Saudi Arabia Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 382: Saudi Arabia 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
    • TABLE 383: Saudi Arabia Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 384: Saudi Arabia Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 385: Saudi Arabia 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 386: Saudi Arabia Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 387: Saudi Arabia Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 388: Saudi Arabia 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 389: UAE Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 390: UAE Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 391: UAE 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 392: UAE Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 393: UAE Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 394: UAE 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
    • TABLE 395: UAE Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 396: UAE Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 397: UAE 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 398: UAE Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 399: UAE Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 400: UAE 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 401: Rest of Middle East Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 402: Rest of Middle East Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 403: Rest of Middle East 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 404: Rest of Middle East Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 405: Rest of Middle East Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 406: Rest of Middle East 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
    • TABLE 407: Rest of Middle East Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 408: Rest of Middle East Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 409: Rest of Middle East 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 410: Rest of Middle East Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 411: Rest of Middle East Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 412: Rest of Middle East 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030
  • AFRICA
    • Enzyme Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 413: Africa Recent Past, Current & Future Analysis for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 414: Africa Historic Review for Enzyme Immunoassays by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 415: Africa 15-Year Perspective for Enzyme Immunoassays by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 416: Africa Recent Past, Current & Future Analysis for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 417: Africa Historic Review for Enzyme Immunoassays by Application - Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 418: Africa 15-Year Perspective for Enzyme Immunoassays by Application - Percentage Breakdown of Value Sales for Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications, Therapeutic Drug Monitoring and Oncology for the Years 2015, 2025 & 2030
    • TABLE 419: Africa Recent Past, Current & Future Analysis for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 420: Africa Historic Review for Enzyme Immunoassays by End-Use - Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 421: Africa 15-Year Perspective for Enzyme Immunoassays by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Clinical Laboratories, Pharma & Biotech Companies, Academic Research Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 422: Africa Recent Past, Current & Future Analysis for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 423: Africa Historic Review for Enzyme Immunoassays by Specimen - Blood, Saliva, Urine and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 424: Africa 15-Year Perspective for Enzyme Immunoassays by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine and Other Specimens for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제